Vasogen
Vasogen, Inc. was a Canadian biotechnology company that pursued immunomodulatory therapies for inflammatory and autoimmune diseases. The firm developed a platform approach intended to modulate immune signaling and vascular inflammation, with research programs spanning preclinical work and early-stage clinical development. Vasogen's strategy reflected a wider industry focus on translating basic insights about cytokines and inflammatory pathways into potential therapies for conditions such as chronic inflammatory diseases and cardiovascular inflammation.
During its operation, Vasogen engaged in collaborations with academic institutions and sought external funding to advance
In the broader bioscience landscape, Vasogen stands as an example of the wave of venture-backed biotech firms